Asia Pacific genital herpes treatment market will grow by 6.3% annually with a total addressable market cap of $10,932.1 million over 2023-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 32 tables and 44 figures, this 110-page report “Asia Pacific Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2
Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs
By Route of Administration, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection
By Patient Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male
By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Virus Type 40
3.1 Market Overview by Virus Type 40
3.2 HSV-1 42
3.3 HSV-2 43
4 Segmentation of Asia Pacific Market by Drug Type 44
4.1 Market Overview by Drug Type 44
4.2 Acyclovir 46
4.3 Valacyclovir 47
4.4 Famciclovir 48
4.5 Other Drugs 49
5 Segmentation of Asia Pacific Market by Route of Administration 51
5.1 Market Overview by Route of Administration 51
5.2 Oral 53
5.3 Topical 54
5.4 Injection 55
6 Segmentation of Asia Pacific Market by Patient Gender 56
6.1 Market Overview by Patient Gender 56
6.2 Female 58
6.3 Male 59
7 Segmentation of Asia Pacific Market by Distribution Channel 60
7.1 Market Overview by Distribution Channel 60
7.2 Retail Pharmacies 62
7.3 Hospital Pharmacies 63
7.4 Online Pharmacies 64
7.5 Drug Stores 65
8 Asia-Pacific Market 2022-2032 by Country 66
8.1 Overview of Asia-Pacific Market 66
8.2 Japan 69
8.3 China 72
8.4 Australia 74
8.5 India 76
8.6 South Korea 78
8.7 Rest of APAC Region 80
9 Competitive Landscape 82
9.1 Overview of Key Vendors 82
9.2 New Product Launch, Partnership, Investment, and M&A 85
9.3 Company Profiles 86
Abbott 86
ADLEY FORMULATIONS 88
Aurobindo Pharma Ltd. 89
Avet Pharmaceuticals Inc. 90
Bausch Health Companies 91
Centurion Remedies 92
Cipla Ltd. 93
Eli Lilly & Company 94
Finecure Pharmaceuticals 95
GlaxoSmithKline Plc 96
Glenmark Pharmaceuticals 97
Macleods Pharmaceuticals 98
Medico Remedies 99
Merck & Co., Inc. 100
Novartis AG 101
Pfizer 102
Reddy's Laboratories 103
Sanofi SA 104
Teva Pharmaceutical Industries Ltd. 105
Torrent Pharma 106
Viatris Inc. 107
Zeelab Pharmacy 108
Zydus Pharmaceuticals, Inc. 109
RELATED REPORTS 110
List of Tables:
Table 1. Snapshot of Asia Pacific Genital Herpes Treatment Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Genital Herpes Treatment Market 32
Table 6. Asia Pacific Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 40
Table 7. Asia Pacific Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 44
Table 8. Side Effects of Genital Herpes Medications 44
Table 9. Vaccine Pipelines for Herpes 50
Table 10. Asia Pacific Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn 51
Table 11. Asia Pacific Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn 56
Table 12. Asia Pacific Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 60
Table 13. APAC Genital Herpes Treatment Market by Country, 2022-2032, $ mn 67
Table 14. Japan Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 71
Table 15. Japan Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 71
Table 16. Japan Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 71
Table 17. China Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 73
Table 18. China Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 73
Table 19. China Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 73
Table 20. Australia Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 75
Table 21. Australia Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 75
Table 22. Australia Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 75
Table 23. India Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 77
Table 24. India Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 77
Table 25. India Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 77
Table 26. South Korea Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn 79
Table 27. South Korea Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn 79
Table 28. South Korea Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn 79
Table 29. Genital Herpes Treatment Market in Rest of APAC by Country/Region, 2022-2032, $ mn 81
Table 30. Abbott: Company Snapshot 86
Table 31. Abbott: Business Segmentation 87
Table 32. Abbott: Product Portfolio 87
